omega-n-methylarginine has been researched along with ularitide in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (ularitide) | Trials (ularitide) | Recent Studies (post-2010) (ularitide) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 210 | 41 | 22 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broadley, AJ; Cockcroft, JR; Frenneaux, MP; Gunaruwan, P; Lee, L; Nightingale, AK; Payne, N; Schmitt, M; Struthers, AD; Taylor, J; Tyberg, JV | 1 |
1 other study(ies) available for omega-n-methylarginine and ularitide
| Article | Year |
|---|---|
Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Atrial Natriuretic Factor; Cardiovascular Agents; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Heart Failure; Humans; Injections, Intra-Arterial; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Natriuretic Peptides; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Peptide Fragments; Tetrahydroisoquinolines; Vascular Resistance; Vasodilation; Veins | 2004 |